Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
The practice's commitment to listening and believing patients ensures concerns are heard and treatment plans align with individual goals and values
Tsaousidou E, Paeger L, Belgardt BF, Pal M, Wunderlich CM, Brnneke H, Collienne U, Hampel B, Wunderlich FT, Schmidt-Supprian M, Kloppenburg P, Brning JC (2014) Distinct roles for JNK and IKK activation in Agouti-related peptide neurons in the development of obesity and insulin resistance
173 MiljanichG